Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Expert group consensus from the Arabian Peninsula on the diagnosis of Late Onset Pompe Disease (LOPD)

Expert group consensus from the Arabian Peninsula on the diagnosis of Late Onset Pompe Disease (LOPD)

Expert group consensus from the Arabian Peninsula on the diagnosis of Late Onset Pompe Disease for Orthopedists

Expert group consensus from the Arabian Peninsula on the diagnosis of Late Onset Pompe Disease for Orthopedists

Differential diagnosis of Late Onset Pompe Disease (LOPD) and myotonic dystrophy type 1 through abdominal ultrasonography

Differential diagnosis of Late Onset Pompe Disease (LOPD) and myotonic dystrophy type 1 through abdominal ultrasonography

The InRange Study

The InRange Study

Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options

Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options

Prevalence of LOPD in patients with undifferentiated proximal myopathy and undiagnosed muscle biopsy

Prevalence of LOPD in patients with undifferentiated proximal myopathy and undiagnosed muscle biopsy

Expert group consensus from the Arabian Peninsula on the diagnosis of LOPD

Expert group consensus from the Arabian Peninsula on the diagnosis of LOPD

Hear from an expert on what does Dupixent bring to your practice?

Hear from an expert on what does Dupixent bring to your practice?

Extraordinary measures: what are the benefits to have such movies talking about Rare Diseases?

Extraordinary measures: what are the benefits to have such movies talking about Rare Diseases?

Expert opinions: Would you consider a biologic for a CRSwnp patient who has had Sinus surgery?

Expert opinions: Would you consider a biologic for a CRSwnp patient who has had Sinus surgery?

Hear from an expert on how does Dupixent target Underlying Type 2 Inflammation?

Hear from an expert on how does Dupixent target Underlying Type 2 Inflammation?

Time-In-Range (TIR): How to interpret it and how it is associated with outcomes

Time-In-Range (TIR): How to interpret it and how it is associated with outcomes